Cancer registry tracks patient experience with Cutting-Edge drugs

NCT ID NCT03816683

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study created a patient registry to observe how newer, targeted cancer drugs work in everyday practice for people with mantle cell lymphoma. It followed 227 patients who had recently started one of these newer treatments to track their treatment patterns, how well the drugs worked, side effects, and how patients felt during treatment. The goal was to gather real-world information to better understand the benefits and challenges of these therapies outside of controlled clinical trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Montgomery, Alabama, 36101, United States
Research Site

Clovis, California, 93611, United States
Research Site

Boulder, Colorado, 80303-1385, United States
Research Site

Jacksonville, Florida, 32256, United States
Research Site

Pensacola, Florida, 32503, United States
Research Site

Tampa, Florida, 33612-9497, United States
Research Site

Atlanta, Georgia, 30322, United States
Research Site

Augusta, Georgia, 30912, United States
Research Site

Chicago, Illinois, 60612, United States
Research Site

Iowa City, Iowa, 52242, United States
Research Site

Ann Arbor, Michigan, 48109, United States
Research Site

Duluth, Minnesota, 55805, United States
Research Site

Saint Louis Park, Minnesota, 55416, United States
Research Site

Saint Paul, Minnesota, 55102, United States
Research Site

Lincoln, Nebraska, 68510, United States
Research Site

Berkeley Heights, New Jersey, 07922, United States
Research Site

Hackensack, New Jersey, 07601, United States
Research Site

East Syracuse, New York, 13057, United States
Research Site

New York, New York, 10022, United States
Research Site

Eugene, Oregon, 97401-8122, United States
Research Site

Danville, Pennsylvania, 17822, United States
Research Site

Philadelphia, Pennsylvania, 19104, United States
Research Site

Philadelphia, Pennsylvania, 19111, United States
Research Site

Nashville, Tennessee, 37232, United States
Research Site

Dallas, Texas, 75231, United States
Research Site

Dallas, Texas, 75390, United States
Research Site

Houston, Texas, 77030, United States
Research Site

San Antonio, Texas, 78229, United States
Research Site

Seattle, Washington, 98122, United States
Research Site

Seattle, Washington, 98195-9472, United States
Research Site

Morgantown, West Virginia, 26506, United States
Research Site

Milwaukee, Wisconsin, 53226, United States

Conditions

Explore the condition pages connected to this study.

MANTLE CELL LYMPHOMA